Isotopes – Talk Bio

Bristol Myers Squibb Resumes Radiopharmaceutical Phase 3 Trial Following Isotope Shortage

9 months ago talkbio0Tagged actinium-225, Isotopes, Myers, Phase 3 trial, Radiopharmaceuticals, RYZ101, shortage, squibb

Bristol Myers Squibb, Radiopharmaceutical, Phase 3 Trial, Isotope Shortage, RYZ101, Actinium-225

ITM Secures €188 Million to Enhance Radiopharmaceutical Pipeline and Strengthen Medical Radioisotope Manufacturing

11 months ago talkbio0Tagged actinium-225, Authority, BlackRock, cancer pipeline, Gastro-enteropancreatic neuroendocrine tumor, Investments, Isotopes, medical radioisotopes, Munich, Qatar, Radiopharmaceuticals, SLC22A18 gene, Technology, Temasek

ITM Isotope Technologies Munich, radiopharmaceutical biotech, Temasek, BlackRock, Qatar Investment Authority, medical radioisotopes, Lutetium-177, Actinium-225, cancer pipeline, gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Novartis Invests $180M in PeptiDream to Boost Radiopharmaceutical Development

12 months ago talkbio0Tagged Cancer Therapeutic Procedure, cellular targeting, Drug Development, Investments, Isotopes, Novartis, Partnership, PeptiDream, Radioactivity, Radiopharmaceuticals

Novartis, PeptiDream, radiopharmaceuticals, investment, drug development, partnership, targeted therapies, cancer treatment, radioactive isotopes.